Opioid supraspinal analgesic synergy between the amygdala and periaqueductal gray in rats

Brain Research

Volumn 779, Issue 1-2, 1998, Pages 158-169

  Pavlovic, Zoran W ^a   Bodnar, Richard J ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Endorphin; Amygdala; Analgesia; Morphine; Nociception; Pain; Periaque ductal gray; Synergy

Indexed keywords

BETA ENDORPHIN; BETA FUNALTREXAMINE; MORPHINE; NALTREXONE; NALTRINDOLE; OPIATE; SIGMA OPIATE RECEPTOR;

AMYGDALOID NUCLEUS; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; LOCUS CERULEUS; MALE; NOCICEPTION; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

AMYGDALA; ANALGESICS, OPIOID; ANIMALS; BETA-ENDORPHIN; MALE; MICROINJECTIONS; MORPHINE; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031985549     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01115-3     Document Type: Article

References (82)

1. Al-Rodhan N., Chipkin R., Yaksh T.L. The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqueductal gray, ventral medulla and amygdala. Brain Res. 520:1990;123-130.
2. Baron S.A., Gintzler A.R. Pregnancy-induced analgesia: effects of adrenalectomy and glucocorticoid replacement. Brain Res. 321:1984;341-346.
3. Baron S.A., Gintzler A.R. Effects of hypophysectomy and dexamethasone treatment on plasma β-endorphin and pain threshold during pregnancy. Brain Res. 418:1987;138-145.
4. Basbaum A.I., Fields H.L. The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: further studies in the anatomy of pain modulation. J. Comp. Neurol. 187:1979;513-532.
5. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7:1984;309-338.
6. Beitz A.J. The organization of afferent projections to the midbrain periaqueductal gray of the rat. Neuroscience. 7:1982;133-159.
7. Bodnar R.J. Neuropharmacological and neuroendocrine substrates of stress-induced analgesia. Ann. NY Acad. Sci. 467:1986;345-360.
8. Bodnar R.J., Paul D., Pasternak G.W. Synergistic analgesic interactions between the periaqueductal gray and the locus coeruleus: studies with the partial μ-1 agonist ethylketocyclazocine. Brain Res. 558:1991;224-230.
9. Bolles R.C., Fanselow M.S. A perceptual-defensive-recuperative model of fear and pain. Behav. Brain Sci. 3:1980;291-323.
10. Carr K.D., Bonnet K.A., Simon E.J. Mu and κ opioid agonists elevate brain stimulation threshold for escape by inhibiting aversion. Brain Res. 245:1982;389-393.
11. Carr K.D., Coons E.E. Lateral hypothalamic stimulation gates nucleus gigantocellularis-induced aversion via a reward-independent process. Brain Res. 232:1982;293-316.
12. Carr K.D., Coons E.E. Rats self-administer nonrewarding brain stimulation to ameliorate aversion. Science. 215:1982;1516-1517.
13. Carr K.D., Uysal S. Evidence of a supraspinal opioid analgesic mechanism engaged by lateral hypothalamic electrical stimulation. Brain Res. 335:1985;55-62.
14. Cox V.C., Valenstein E.S. Attenuation of aversive properties of peripheral shock by hypothalamic stimulation. Science. 149:1965;323-325.
15. Da Costa Gomez T.M., Behbehani M.M. An electrophysiological characterization of the projection from the central nucleus of the amygdala to the periaqueductal gray of the rat: the role of opioid receptors. Brain Res. 689:1995;21-31.
16. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
17. M. Davis, The role of the amygdala in conditioned fear, in: J.P. Aggleton (Ed.), The Amygdala, Wiley-Liss, New York, 1992, pp. 255-306.
18. J. deOlmos, G.F. Alheid, C. Beltramino, in: G. Paxinos (Ed.), Amygdala, The rat Nervous System I, Forebrain and Midbrain, Academic Press, New York, 1985, pp. 223-334.
19. Evans W.O. A new technique for the investigation of some analgesic drugs on a reflexive behavior in the rat. Psychopharmacology. 2:1961;318-325.
20. Fanselow M.S. Opiate modulation of the active and inactive components of the postshock reaction: parallels between naloxone pretreatment and shock intensity. Behav. Neurosci. 98:1984;269-277.
21. Fox R.J., Sorenson C.A. Bilateral lesions of the amygdala attenuate analgesia induced by diverse environmental challenges. Brain Res. 648:1994;215-221.
22. Gintzler A.R. Endorphin-mediated increases in pain threshold during pregnancy. Science. 210:1980;193-195.
23. Gintzler A.R., Peters L.C., Komisaruk B.R. Attenuation of pregnancy-induced analgesia by hypogastric neurectomy in rats. Brain Res. 227:1983;186-188.
24. Grossman M.L., Basbaum A.I., Fields H.L. Afferent and efferent connections of the rat tail-flick reflex (a model to analyze pain control mechanisms). J. Comp. Neurol. 206:1982;9-16.
25. Helmstetter F.J. The amygdala is essential for the expression of conditional hypoalgesia. Behav. Neurosci. 106:1992;518-528.
26. Helmstetter F.J., Bellgowan P.S. Lesions of the amygdala block conditional hypoalgesia on the tail-flick test. Brain Res. 612:1993;253-257.
27. Helmstetter F.J., Bellgowan P.S.F., Poore L.H. Microinfusions of μ, but not δ or κ opioid agonists into the basolateral amygdala results in inhibition of the tail-flick reflex in pentobarbital-anesthetized rats. J. Pharmacol. Exp. Ther. 275:1995;381-388.
28. Helmstetter F.J., Bellgowan P.S., Tershner S.A. Inhibition of the tail-flick reflex following microinjection of morphine into the amygdala. Neuroreport. 4:1993;471-474.
29. Helmstetter F.J., Fanselow M.S. Effects of naltrexone on the learning and performance of conditional fear-induced freezing and opioid analgesia. Physiol. Behav. 39:1987;501-505.
30. F.J. Helmstetter, S.A. Tershner, L.H. Poore, P.S.F. Bellgowan, Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla, Brain Res., (1997) in press.
31. Iwasaki H., Collins J.G., Saito Y., Kerman-Hinds A. Naloxone-sensitive, pregnancy-induced changes in behavioral responses to colorectal distension: pregnancy-induced analgesia to visceral stimulation. Anesthesiology. 74:1991;927-933.
32. Kalivas P.W., Gau B.A., Nemeroff C.B., Prange A.J. Antinociception after microinjection of neurotensin into the central amygdaloid nucleus of the rat. Brain Res. 243:1982;279-286.
33. Kelly D.D. The role of endorphins in stress-induced analgesia. Ann. NY Acad. Sci. 398:1982;260-271.
34. Kiefel J.M., Rossi G.C., Bodnar R.J. Medullary μ and δ opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624:1993;151-160.
35. Klamt J.G., Prado W.A. Antinociception and behavioral changes induced by carbachol microinjected into identified sites of the rat brain. Brain Res. 549:1991;9-18.
36. Krettek J.E., Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J. Comp. Neurol. 178:1978;225-254.
37. Kristal M.B., Thompson A.C., Abbott P., DiPirro J.M., Ferguson E.J., Doerr J.C. Amniotic-fluid ingestion by parturient rats enhances pregnancy-mediated analgesia. Life Sci. 46:1990;693-698.
38. J.E. LeDoux, Emotion and the amygdala, in: J.P. Aggleton (Ed.), The Amygdala, Wiley-Liss, New York, 1992, pp. 339-351.
39. Lichtman A.H., Fanselow M.S. Opioid and nonopioid conditional analgesia: the role of spinal opioid, noradrenergic and serotonergic systems. Behav. Neurosci. 105:1991;687-698.
40. Manning B.H., Mayer D.J. The central nucleus of the amygdala contributes to the production of morphine antinociception in the tail-flick test. J. Neurosci. 15:1995;8199-8213.
41. Manning B.H., Mayer D.J. The central nucleus of the amygdala contributes to the production of morphine antinociception in the formalin test. Pain. 63:1995;141-152.
42. D.J. Mayer, B.H. Manning, The role of opioid peptides in environmentally-induced analgesia, in: L.F. Tseng (Ed.), The Pharmacology of Opioid Peptides, Harwood Academic, 1995, pp. 345-395.
43. Miyamoto Y., Morita N., Kitabata Y., Yamanishi T., Kishioka S., Ozaki M., Yamamoto H. Antinociceptive synergism between supraspinal and spinal sites after subcutaneous morphine evidenced by CNS morphine content. Brain Res. 552:1991;136-140.
44. Monroe P.J., Hawranko A.A., Smith D.L., Smith D.J. Biochemical and pharmacological characterization of multiple β-endorphinergic antinociceptive systems in the rat periaqueductal gray. J. Pharmacol. Exp. Ther. 276:1996;65-93.
45. Pavlovic Z.W., Cooper M.L., Bodnar R.J. Enhancements in swim stress-induced hypothermia, but not analgesia following amygdala lesions in rats. Physiol. Behav. 59:1996;77-82.
46. Pavlovic Z.W., Cooper M.L., Bodnar R.J. Opioid antagonists in the periaqueductal gray inhibit morphine and β-endorphin analgesia elicited from the amygdala of rats. Brain Res. 741:1996;13-26.
47. Pick C.G., Nejat R.J., Pasternak G.W. Independent expression of two pharmacologically distinct supraspinal μ analgesic systems in genetically-different mouse strains. J. Pharmacol. Exp. Ther. 265:1993;166-171.
48. Pick C.G., Roques B., Gacel G., Pasternak G.W. Supraspinal μ-2 receptors mediate spinal/supraspinal morphine synergy. Eur. J. Pharmacol. 220:1992;275-277.
49. Price J.L., Amaral D.G. An autoradiographic study of the projections of the central nucleus of the amygdala. J. Neurosci. 1:1981;1242-1259.
50. Rizvy T.A., Ennis M., Behbehani M.M., Shipley M.T. Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity. J. Comp. Neurol. 303:1991;121-131.
51. Rodgers R.J. Elevation of aversive threshold in rats by intra-amygdaloid injection of morphine sulphate. Pharmacol. Biochem. Behav. 6:1977;385-390.
52. Rodgers R.J. Influence of intra-amygdaloid opiate injections on shock thresholds, tail-flick latencies and open field behaviour in rats. Brain Res. 153:1978;211-216.
53. Roerig S.C., Fujimoto J.M. Multiplicative interactions between intrathecally and intracerebroventricularly administered μ opioid agonists but limited interactions between δ and κ agonists for antinociception in mice. J. Pharmacol. Exp. Ther. 249:1989;762-767.
54. Roerig S.C., Fujimoto J.M., Tseng L.F. Comparisons of descending pain inhibitory pathways activated by β-endorphin and morphine as characterized by supraspinal and spinal antinociceptive interactions in mice. J. Pharmacol. Exp. Ther. 247:1988;1107-1113.
55. Roerig S.C., O'Brien S.M., Fujimoto J.M., Wilcox G.L. Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites. Brain Res. 302:1984;360-363.
56. Rossi G.C., Pasternak G.W., Bodnar R.J. Synergistic brainstem interactions for morphine analgesia. Brain Res. 624:1993;171-180.
57. Rossi G.C., Pasternak G.W., Bodnar R.J. Mu and δ opioid synergy between the periaqueductal gray and the rostro-ventral medulla. Brain Res. 665:1994;85-93.
58. Roychowdhury S.M., Fields H.L. Endogenous opioids acting at a medullary μ-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray. Neuroscience. 74:1996;863-872.
59. Sander H.W., Portoghese P.S., Gintzler A.R. Spinal κ opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphamine, a κ-selective antagonist. Brain Res. 474:1988;343-347.
60. Siuciak J.A., Advokat C. The synergistic effects of concurrent spinal and supraspinal opiate agonisms is reduced by both nociceptive and morphine pretreatment. Pharmacol. Biochem. Behav. 34:1989;265-273.
61. Smith D.J., Robertson B., Monroe P.J. Antinociception from the administration of β-endorphin into the periaqueductal gray is enhanced while that of morphine is inhibited by barbiturate anesthesia. Neurosci. Lett. 146:1992;143-146.
62. Smith D.J., Robertson B., Monroe P.J., Leedham J.A., Cabral J.D.Y. Opioid receptors mediating antinociception from β-endorphin and morphine in the periaqueductal gray. Neuropharmacology. 31:1992;1137-1150.
63. Stellar J.R., Brooks F.H., Mills L.E. Approach and withdrawal analysis of the effects of hypothalamic stimulation and lesions in rats. J. Comp. Physiol. Psychol. 93:1979;446-466.
64. Suh H.H., Fujimoto J.M., Tseng L.F. Differential mechanisms mediating β-endorphin- and morphine-induced analgesia in mice. Eur. J. Pharmacol. 168:1989;61-70.
65. Suh H.H., Tseng L.F. Delta but not μ-opioid receptors in the spinal cord are involved in antinociception induced by β-endorphin given intracerebroventricularly in mice. J. Pharmacol. Exp. Ther. 253:1990;981-986.
66. Suh H.H., Tseng L.F. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered β-endorphin and morphine or DPDPE in mice. Life Sci. 46:1990;759-765.
67. Suh H.H., Tseng L.F., Li C.H. β-Endorphin (1-27) antagonizes β-endorphin-, but not morphine-, DPDPE- and U50488H-induced analgesia in mice. Neuropharm. 27:1988;957-963.
68. Terman G.W., Shavit Y., Lewis J.W., Cannon J.T. Intrinsic mechanisms of pain inhibition: activation by stress. Science. 226:1984;1270-1277.
69. Tershner S.A., Helmstetter F.J. Spinal antinociception following stimulation of the amygdala depends on opioid receptors in the ventral periaqueductal gray. Soc. Neurosci. Abstr. 21:1995;1169.
70. L.F. Tseng, Mechanisms of β-endorphin-induced antinociception, in: L.F. Tseng (Ed.), The Pharmacology of Opioid Peptides, Harwood, Chur, Switzerland, 1995, p. 249.
71. Tseng L.F., Collins K.A. Different mechanisms mediating tail-flick inhibition induced by β-endorphin, DAMGO and morphine from ROb and GiA in anesthetized rats. J. Pharmacol. Exp. Ther. 257:1991;530-538.
72. Tseng L.F., Fujimoto J.M. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular β-endorphin and morphine in rats. J. Pharmacol. Exp. Ther. 232:1985;74-79.
73. Tseng L.F., Higgins M.J., Hong J.S., Hudson P.M., Fujimoto J.M. Release of immunoreactive met-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized rats. Brain Res. 343:1985;60-69.
74. Tseng L.F., Suh H.H. Intrathecal [Met5]-enkephalin antibody blocks analgesia induced by intracerebroventricular β-endorphin but not morphine in mice. Eur. J. Pharmacol. 173:1989;171-176.
75. Tseng L.F., Tang R. Different mechanisms mediate β-endorphin- and morphine-induced inhibition of the tail-flick response in rats. J. Pharmacol. Exp. Ther. 252:1990;546-551.
76. Tseng L.F., Tang R.R. Pentobarbital attenuates antinociception induced by i.c.v. morphine but not β-endorphin in the mouse. Eur. J. Pharmacol. 214:1992;175-180.
77. Tseng L.F., Wang Q. Forebrain sites differentially sensitive to β-endorphin and morphine for analgesia and release of met-enkephalin in the pentobarbital-anesthetized rat. J. Pharmacol. Exp. Ther. 261:1992;1028-1036.
78. Watkins L.R., Wiertelak E.P., Maier S.F. The amygdala is necessary for the expression of conditioned but not unconditioned analgesia. Behav. Neurosci. 107:1993;402-405.
79. Yaksh T.L., Yeung J.A., Rudy T.A. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observations of differential effects within the periaqueductal gray. Brain Res. 114:1976;83-103.
80. Yeung J.C., Rudy T.A. Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. J. Pharmacol. Exp. Ther. 215:1980;633-642.
81. Young E.G., Watkins L.R., Mayer D.J. Comparison of the effects of ventral medullary lesions on systemic and microinjection morphine analgesia. Brain Res. 290:1984;119-129.
82. Yunger L.M., Harvey J.A., Lorens S.A. Dissociation of the analgesic and rewarding effects of brain stimulation in the rat. Physiol. Behav. 10:1973;909-913.